NanoViricides Inc. (NNVC)

[jg35]

You don't have to work in the biotech industry to see that most highly speculative ventures based on bleeding edge science fail. Yes, biotech is one of the few places where you can get 10 baggers on your investment. That's because for every 10 bagger there are 9 other biotechs that looked equally promising and went to 0. For a startup biotech the most common way to fail is to run out of money before it has a product proven to work. NNVC has a good chance of going out in precisely that way. Big pharma won't come breaking down the door just because toxicity studies or phase 1 trials have completed. Those studies merely show that the product doesn't kill people. Big pharma will be willing to make a big investment after a successful phase 2 trial of sufficient size and statistical significance to convince a skeptic that he should part with many millions of dollars of his money. I don't give NNVC better than even odds of that happening before they run out of money.